biopharmadive.com /1 week ago

Translating Phase II success into Phase III readiness takes more than scale

The move from Phase II to Phase III is often treated as a clinical milestone, when it is actually a development-wide transition.

Read source
newswire.com /2 weeks ago

Moderna Advances Investigational Bundibugyo Ebolavirus Vaccine Toward Phase 2/3 Study

WHO Technical Advisory Group recommends mRNA-1469 for inclusion in efficacy study following encouraging Phase 1 clinical results

Read source
qchron.com /1 month ago

First Patient Dosed in Phase III Perioperative Study of Cadonilimab (PD-1/CTLA-4) in Colon Cancer

HONG KONG, Oct. 10, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study (COMPASSION-...

Read source
multiplesclerosisnewstoday.com /1 month ago

New therapy moves closer to Phase 2 testing in progressive MS

Quantum Biopharma is collaborating with Thermo Fisher Scientific to prepare a Phase 2 clinical trial of Lucid-MS, an experimental oral therapy designed to slow myelin loss, in peop...

Read source
newswire.com /1 month ago

Ensysce Biosciences Phase 2 Protocol for CY200 - A Neuroplastigen for the Treatment of CRPS - Submitted to the UK MHRA

~ Submission to the UK MHRA for review marks critical step towards initiating a Phase 2 Study with CY200 ~

Read source
parkinsonsnewstoday.com /6 days ago

European project backs Phase 2 trial of potential Parkinson’s therapy

A new €8 million (about $8.8 million) European research project will support a Phase 2 trial of HER-096, Herantis Pharma’s experimental therapy designed to protect nerve cells and...

Read source
parkinsonsnewstoday.com /1 month ago

First patient dosed in clinical trial of oral treatment for Parkinson’s

The first patient has been dosed in Mission Therapeutics’ Phase 1b clinical trial of MTX325, an oral treatment for Parkinson’s disease. With several locations open in the U.K., Fra...

Read source
newswire.com /1 month ago

IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer's Trial; Topline Results Expected Q4 2026

IGC Pharma completes Phase 2 CALMA enrollment with 168 participants randomized, advancing toward database lock and expected Q4 2026 topline results.

Read source
newswire.com /4 days ago

IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia

Final participant completes dosing in 170-participant trial; topline results anticipated during the December 2026/January 2027 timeframe

Read source
parkinsonsnewstoday.com /1 month ago

First patient dosed in Phase 2a oral therapy trial for Parkinson’s disease

The first patient has been dosed in a Phase 2a clinical trial evaluating Jotrol, an investigational oral formulation of resveratrol that Jupiter Neurosciences is developing for Par...

Read source
psychedelicalpha.com /6 days ago

Breaking: Helus’ Deuterated Psilocin Hits Primary Endpoint in First Phase 3

This morning, Helus Pharma (formerly Cybin) announced a positive topline readout from its first Phase 3 study of HLP003, a deuterated psilocin analog, for the adjunctive treatment...

Read source
newswire.com /1 month ago

Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or abo...

Read source
qchron.com /6 days ago

How Clinical Trials Really Work: Understanding the 4 Phases

Read source
snacksafely.com /1 month ago

Novartis Launches Phase III Trial of Pill That Could Help Protect Against Reactions

Novartis is testing an experimental pill that could help protect people with food allergies from accidental exposure. The post Novartis Launches Phase III Trial of Pill That Could...

Read source
africanews.com /1 month ago

Phase-1 trial of Ebola vaccine gets underway in Uganda

Scientists in the southern Ugandan city of Masaka are conducting a phase I trial of a candidate vaccine against the deadly Ebola Bundibugyo virus disease (BDBV), a strain for which...

Read source
theeastafrican.co.ke /1 month ago

Uganda trials Ebola vaccine as countries rush to tame spread

Phase One trial involves an experimental vaccine candidate known as ChAdOx1 BDBV. It's being conducted by Ugandan researchers alongside colleagues from London and University of Oxf...

Read source
plasticsurgerypractice.com /1 month ago

Phase 3 Trial Shows Injectable Treatment Reduces Submental Fat

The injectable treatment showed a 30-percentage-point advantage over placebo in submental fat responder rates after a single treatment cycle, supporting plans for a regulatory fili...

Read source
goodmenproject.com /3 days ago

How Clinical Trials Really Work: Understanding the 4 Phases

Explore the four phases of clinical trials, from initial safety testing to large-scale studies evaluating treatment effectiveness and long-term risks. The post How Clinical Trials...

Read source
oxfordstudent.com /1 month ago

Oxford-developed Ebola vaccine enters Phase I clinical trial in Uganda

An Oxford-developed vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus caused by Bundibugyo virus (BDBV), entered a Phase I clinical study in Uganda on 6t...

Read source
medcitynews.com /1 month ago

Phase 3 Data Could Make Roche Drug a Contender to Treat Rare Kidney Disease`

Roche reported the drug sefaxersen achieved statistically significant and clinically meaningful results in a Phase 3 test in immunoglobulin A nephropathy, or IgAN. This antisense o...

Read source
pharmexec.com /1 month ago

<![CDATA[What Actually Went Wrong When a Phase 3 Trial Fails: Q&A with Dr. Remo Moomiaie-Qajar]]>

Read source
oxfordmail.co.uk /2 weeks ago

Oxford psilocybin depression study reaches final participant milestone

The final participant has completed their last visit in the COMP006 study at Oxford, marking the end of the active delivery phase at the NIHR Clinical Research Facility (CRF).

Read source
parkinsonsnewstoday.com /3 weeks ago

Enrollment complete in trial of experimental Parkinson’s treatment

Vertero Therapeutics has completed patient enrollment in a Phase 1b clinical trial testing VT-5006, an experimental treatment designed to target gut-related mechanisms believed to...

Read source
parkinsonsnewstoday.com /1 month ago

Trial of experimental Parkinson’s vaccine shows positive initial results

ACI-7104, AC Immune’s experimental vaccine for early Parkinson’s disease, was generally safe and triggered an immune response against aggregated alpha-synuclein, according to resul...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.